The current PE ratio of NEOG cannot be calculated, as the latest EPS of -$2.19 is negative. The last PE ratio of Neogen, recorded in February 2024, was 859.5.
The PE ratio of Neogen has averaged 107.38 over the last ten years. Analyzing the last ten years, NEOG's PE ratio reached its highest point in the Feb 2024 quarter at 859.5, when the price was $17.19 and the EPS was $0.02. The lowest point was recorded in the May 2019 quarter, when it reached 48.58 with a price of $28.18 and an EPS of $0.58.
Maximum annual increase: 39.98% in 2010
Maximum annual decrease: -27.38% in 2022
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | N/A | N/A | $13.15 | -$0.04 |
2023 | N/A | N/A | $17.49 | -$0.12 |
2022 | 58.8 | -27.38% | $26.46 | $0.45 |
2021 | 80.97 | 29.61% | $46.16 | $0.57 |
2020 | 62.47 | 28.59% | $35.61 | $0.57 |
2019 | 48.58 | -20.44% | $28.18 | $0.58 |
2018 | 61.06 | 13.2% | $37.86 | $0.62 |
2017 | 53.94 | 7.79% | $23.73 | $0.44 |
2016 | 50.04 | -2.93% | $18.51 | $0.37 |
2015 | 51.55 | 5.48% | $17.53 | $0.34 |
2014 | 48.87 | 4.07% | $14.17 | $0.29 |
2013 | 46.96 | 15.78% | $13.62 | $0.29 |
2012 | 40.56 | -9.55% | $9.74 | $0.24 |
2011 | 44.84 | 39.51% | $11.21 | $0.25 |
2010 | 32.14 | 39.98% | $6.43 | $0.2 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Nov 2024 | N/A | N/A | $14.18 | -$2.19 |
Aug 2024 | N/A | N/A | $17.25 | -$0.11 |
May 2024 | N/A | N/A | $13.15 | -$0.04 |
Feb 2024 | 859.5 | 254.54% | $17.19 | $0.02 |
Nov 2023 | 242.43 | N/A | $16.97 | $0.07 |
Aug 2023 | N/A | N/A | $23.12 | -$0.1 |
May 2023 | N/A | N/A | $17.49 | -$0.12 |
Feb 2023 | 442.25 | 33.53% | $17.69 | $0.04 |
Nov 2022 | 331.2 | 438.8% | $16.56 | $0.05 |
Aug 2022 | 61.47 | 4.54% | $20.9 | $0.34 |
May 2022 | 58.8 | -24.24% | $26.46 | $0.45 |
Feb 2022 | 77.61 | 4.44% | $35.7 | $0.46 |
Nov 2021 | 74.31 | 0.15% | $40.13 | $0.54 |
Aug 2021 | 74.2 | -8.36% | $43.78 | $0.59 |
May 2021 | 80.97 | 16.64% | $46.16 | $0.57 |
Stock name | PE ratio | Market cap |
---|---|---|
TMO Thermo Fisher Scientific Inc | 32.12 | $200.91B |
BDX Becton Dickinson & Co | 38.16 | $65.3B |
DHR Danaher Corp | 39.44 | $150.25B |
IDXX Idexx Laboratories Inc | 42.04 | $36.82B |
ILMN Illumina Inc | N/A | $14.92B |
PACB Pacific Biosciences Of California Inc | N/A | $421.75M |
NEOG Neogen Corp | N/A | $2.18B |
The current price to earnings ratio of NEOG cannot be determined, as its EPS of -$2.19 is negative.
As an average over the last 3 years, NEOG stock has a PE ratio of 296.18.
As an average over the last 5 years, NEOG stock has a PE ratio of 174.57.
Over the last ten years, the quarterly PE ratio reached its highest level at 859.5 in the Feb 2024 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.